MARKET

CHGCF

CHGCF

Chugai Pharmaceu
OTCPK
40.50
NaN%
Closed 09:30 10/05 EDT
OPEN
--
PREV CLOSE
40.50
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
45.00
52 WEEK LOW
40.50
MARKET CAP
66.63B
P/E (TTM)
22.81
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Healthequity (HQY) and Chugai Pharmaceutical Co (OtherCHGCF)
TipRanks · 6d ago
Macquarie Remains a Buy on Chugai Pharmaceutical Co (CHGCF)
TipRanks · 6d ago
Daiwa Keeps Their Buy Rating on Chugai Pharmaceutical Co (CHGCF)
TipRanks · 09/28 10:05
Chugai Takes Back Rights to Emugrobart as Roche Exits Obesity Program, Revives SMA Focus
TipRanks · 09/28 07:39
SBI Securities Sticks to Their Buy Rating for Chugai Pharmaceutical Co (CHGCF)
TipRanks · 09/09 10:15
Crovalimab Trial Completion Signals New PNH Opportunity for Chugai Investors
TipRanks · 09/01 16:30
Nomura Keeps Their Hold Rating on Chugai Pharmaceutical Co (CHGCF)
TipRanks · 09/01 10:06
AQUA07: Chugai’s New ALK Lung Cancer Bet Moves Forward in Early Clinical Testing
TipRanks · 08/19 16:31
More
About CHGCF
CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALECENSA, Kadcyla, GAZYVA, CellCept, Zelboraf, Xeloda, Tamiflu, Tarceva, Tecentriq, Herceptin, Perjeta, cancer gene panel testing and others. These products are primarily used to treat conditions such as cancer, kidney disease and kidney transplantation, bone and joint diseases (rheumatoid arthritis), neurological and muscular diseases (neuromyelitis optica spectrum disorders, spinal muscular atrophy, and Duchenne muscular dystrophy), blood disorders (hemophilia and paroxysmal nocturnal hemoglobinuria), and eye diseases (retinal disorders). It also engages in administrative operations, the provision of scientific information on pharmaceuticals, investment activities, and the provision of influenza information services.

Webull offers Chugai Pharmaceutical Co Ltd stock information, including OTCPK: CHGCF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHGCF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CHGCF stock methods without spending real money on the virtual paper trading platform.